ConductScience.org, home

Paper9502779

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.

Khatri VP and 9 others. J Clin Invest, 1998. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies. Papers, record 9502779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9502779

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.
PubMed
Journal
J Clin Invest
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2018-11-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Khatri VPV P
2Fehniger TAT A
3Baiocchi RAR A
4Yu FF
5Shah MHM H
6Schiller DSD S
7Gould MM
8Gazzinelli RTR T
9Bernstein ZPZ P
10Caligiuri MAM A

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
Interferon-gammaMajor topic
Interleukin-2Major topic
Lymphoma, AIDS-RelatedMajor topic
Sarcoma, KaposiMajor topic
CD4 Lymphocyte Count
CD8-Positive T-Lymphocytes
Flow Cytometry
Gene Expression
Humans
Immunity, Innate
Immunocompromised Host
Immunotherapy
Interleukin-10
Killer Cells, Natural
Leukocytes, Mononuclear
Lipopolysaccharides
Lymphocyte Count
Polymerase Chain Reaction
T-Lymphocyte Subsets

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-09581NCI NIH HHSUnited StatesT32CA009581PubMed and NIHNIH RePORTER
CA-68456NCI NIH HHSUnited StatesPubMedPubMed
P30CA-16058NCI NIH HHSUnited StatesP30CA016058PubMed and NIHNIH RePORTER

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17559914Biology of human TH1 and TH2 cells.J Clin Immunol1995https://conductscience.org/library/papers/7559914PubMed
27579429
Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity.
Blood1995https://conductscience.org/library/papers/7579429PubMed
38739561Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement.Immunol Res1996https://conductscience.org/library/papers/8739561PubMed
48816813Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8816813PubMed
58820272The expanding universe of T-cell subsets: Th1, Th2 and more.Immunol Today1996https://conductscience.org/library/papers/8820272PubMed
68960473A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection.N Engl J Med1996https://conductscience.org/library/papers/8960473PubMed
78960475Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.N Engl J Med1996https://conductscience.org/library/papers/8960475PubMed
89022011Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells.Eur J Immunol1997https://conductscience.org/library/papers/9022011PubMed
99028322Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response.Blood1997https://conductscience.org/library/papers/9028322PubMed
109045904CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.Eur J Immunol1997https://conductscience.org/library/papers/9045904PubMed
119142122HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.Nat Med1997https://conductscience.org/library/papers/9142122PubMed
121352911Programmed death of T cells in HIV-1 infection.Science1992https://conductscience.org/library/papers/1352911PubMed
138426121Interferon gamma inhibits interleukin 10 production by monocytes.J Exp Med1993https://conductscience.org/library/papers/8426121PubMed
148097322
Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8097322PubMed
158100999Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8100999PubMed
168102262The T cell receptor V beta repertoire in HIV-1 infection and disease.Semin Immunol1993https://conductscience.org/library/papers/8102262PubMed
178409467Constructing polycompetitor cDNAs for quantitative PCR.J Immunol Methods1993https://conductscience.org/library/papers/8409467PubMed
188216925The role of natural killer cells in innate resistance to infection.Curr Opin Immunol1993https://conductscience.org/library/papers/8216925PubMed
198228800Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice.J Exp Med1993https://conductscience.org/library/papers/8228800PubMed
208235617Multifactorial nature of human immunodeficiency virus disease: implications for therapy.Science1993https://conductscience.org/library/papers/8235617PubMed

See all 32 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
33233727The Mediation of miR-34a/miR-449c for Immune Cytokines in Acute Cold/Heat-Stressed Broiler Chicken.Animals (Basel)2020https://conductscience.org/library/papers/33233727PubMed
33102204Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals.Front Oncol2020https://conductscience.org/library/papers/33102204PubMed
31989589Low-dose IL-2 induces CD56bright NK regulation of T cells via NKp44 and NKp46.Clin Exp Immunol2020https://conductscience.org/library/papers/31989589PubMed
26729100Astaxanthin, a Carotenoid, Stimulates Immune Responses by Enhancing IFN-γ and IL-2 Secretion in Primary Cultured Lymphocytes in Vitro and ex Vivo.Int J Mol Sci2015https://conductscience.org/library/papers/26729100PubMed
25054077Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.Scientifica (Cairo)2014https://conductscience.org/library/papers/25054077PubMed
18698048Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant.Clin Cancer Res2008https://conductscience.org/library/papers/18698048PubMed
18171294Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.J Infect Dis2008https://conductscience.org/library/papers/18171294PubMed
16474159Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.J Virol2006https://conductscience.org/library/papers/16474159PubMed
10880055Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy.J Clin Invest2000https://conductscience.org/library/papers/10880055PubMed
10051630Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10051630PubMed
9767056Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.Clin Microbiol Rev1998https://conductscience.org/library/papers/9767056PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9502779

GET https://conductscience.org/api/papers/v1/9502779/references?page=2